Indivior Pharmaceuticals Inc
INDV
株式のランク
#3858
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
株価
$34.51
時価総額
$4.31B
変化（1日）
1.89%
変化（1年）
42.07%
国
US
取引 Indivior Pharmaceuticals Inc (INDV)
カテゴリー
Healthcare
Indivior Pharmaceuticals Inc（INDV）の発行済株式数
June 2026 時点の発行済株式数 125.35M
Indivior Pharmaceuticals Inc の最新の財務報告および株価によると、現在の発行済株式数は 125.35M です。December 2023 の終わりには、同社は 137.31M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Indivior Pharmaceuticals Inc（INDV）の発行済株式数の履歴（2016 ～ 2026）
各年末時点の発行済株式数
| 年 | 発行済株式数 | 変化 |
|---|---|---|
| 2026 (TTM) | 125.35M | -5.04% |
| 2024 | 132.00M | -3.86% |
| 2023 | 137.31M | -1.23% |
| 2022 | 139.01M | -4.56% |
| 2021 | 145.66M | -0.62% |
| 2020 | 146.57M | 0.36% |
| 2019 | 146.05M | 0.42% |
| 2018 | 145.43M | 0.84% |
| 2017 | 144.23M | 0.17% |
| 2016 | 143.97M | 0.00% |
類似企業や競合他社の発行済株式数
| 企業 | 発行済株式数 | 差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 1,814.08% |
IN
|
